These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19054333)

  • 21. Role of oxidative stress in the natriuresis induced by central administration of angiotensin II.
    Israel A; Arzola J; De Jesús S; Varela M
    J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):9-14. PubMed ID: 19286753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteinuric diseases with sodium retention: Is plasmin the link?
    Svenningsen P; Skøtt O; Jensen BL
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):117-24. PubMed ID: 21466573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and urinary ceruloplasmin in experimental nephrotic syndrome.
    Mainero A; Cruz C; Pedraza-Chaverrí J
    Clin Invest Med; 1992 Aug; 15(4):295-300. PubMed ID: 1516286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
    Forte LR
    Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collecting duct is a site of sodium retention in PAN nephrosis: a rationale for amiloride therapy.
    Deschênes G; Wittner M; Stefano AD; Jounier S; Doucet A
    J Am Soc Nephrol; 2001 Mar; 12(3):598-601. PubMed ID: 11181809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
    Stæhr M; Buhl KB; Andersen RF; Svenningsen P; Nielsen F; Hinrichs GR; Bistrup C; Jensen BL
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F235-41. PubMed ID: 25972510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The natriuretic peptide uroguanylin elicits physiologic actions through 2 distinct topoisomers.
    Moss NG; Riguera DA; Solinga RM; Kessler MM; Zimmer DP; Arendshorst WJ; Currie MG; Goy MF
    Hypertension; 2009 May; 53(5):867-76. PubMed ID: 19289652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma natriuretic activity in oedematous states.
    Kramer HJ; Krück F
    Proc Eur Dial Transplant Assoc; 1976; 12():321-9. PubMed ID: 1084525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of uroguanylin, an intestinal natriuretic peptide, on tubuloglomerular feedback.
    Wang T; Kawabata M; Haneda M; Takabatake T
    Hypertens Res; 2003 Jul; 26(7):577-82. PubMed ID: 12924626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats.
    Medeiros M; Pérez-Urizar J; Pedraza-Chaverri J; Muñoz-Arizpe R; Castañeda-Hernández G
    Can J Physiol Pharmacol; 2007 May; 85(5):502-6. PubMed ID: 17632584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome.
    Takamura N; Maruyama T; Chosa E; Kawai K; Tsutsumi Y; Uryu Y; Yamasaki K; Deguchi T; Otagiri M
    Drug Metab Dispos; 2005 Apr; 33(4):596-602. PubMed ID: 15640375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duodenal bicarbonate secretion in rats: stimulation by intra-arterial and luminal guanylin and uroguanylin.
    Bengtsson MW; Jedstedt G; Flemström G
    Acta Physiol (Oxf); 2007 Dec; 191(4):309-17. PubMed ID: 17995576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
    Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphologic, molecular and hemodynamic cardiac alterations in a model of nephropathy induced by puromycin aminonucleoside.
    Moreira-Rodrigues M; Roncon-Albuquerque R; Henriques-Coelho T; Sampaio-Maia B; Leite-Moreira A; Pestana M
    Rev Port Cardiol; 2006 May; 25(5):509-18. PubMed ID: 16910158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine and plasma levels of uroguanylin and its molecular forms in renal diseases.
    Kinoshita H; Fujimoto S; Nakazato M; Yokota N; Date Y; Yamaguchi H; Hisanaga S; Eto T
    Kidney Int; 1997 Oct; 52(4):1028-34. PubMed ID: 9328941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased Excretion of Urinary Exosomal Aquaporin-2 in a Puromycin Aminonucleoside-Induced Nephrotic Syndrome Model.
    Abdeen A; Sonoda H; Kaito A; Oshikawa-Hori S; Fujimoto N; Ikeda M
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of experimental nephrotic syndrome with artesunate.
    Razavi A; Nouri HR; Mehrabian F; Mirshafiey A
    Int J Toxicol; 2007; 26(4):373-80. PubMed ID: 17661229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Water-retention effect of suberogorgin was due to secretion of antidiuretic hormone in rat.
    Peng WD
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):559-62. PubMed ID: 10678154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium-lithium countertransport in children with nephrotic syndrome.
    Tulassay T; Dobos M; Luczay A; Stubnya G; Reusz GS; Vásárhelyi B; Sallay P; Szabó A
    Pediatr Nephrol; 1999 Aug; 13(6):510-3. PubMed ID: 10452280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel role for uroguanylin in the regulation of sodium balance.
    Forte LR
    J Clin Invest; 2003 Oct; 112(8):1138-41. PubMed ID: 14561698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.